The European Medicines Agency has authorized the new manufacturing site in Leipzig for CO.DON AG. The Leipzig site is now formally approved for the manufacture, quality control and marketing of Spherox for the EU. This means that all the official requirements set by the EMA to produce the pharmaceutical product in Leipzig and its distribution within the EU market have been met. The technology transfer process will be completed with a routine inspection by the state authority for Saxony, which The company expects to take place in summer 2021. Spherox production is planned to start in Leipzig in August/September 2021, whereby both sites will initially produce for the EU market in parallel.